Free Trial

Xenon Pharmaceuticals (XENE) Short Interest Ratio & Short Volume

$40.42
+0.62 (+1.56%)
(As of 05/20/2024 ET)

Xenon Pharmaceuticals Short Interest Data

Current Short Interest
2,790,000 shares
Previous Short Interest
2,620,000 shares
Change Vs. Previous Month
+6.49%
Dollar Volume Sold Short
$113.41 million
Short Interest Ratio
7.8 Days to Cover
Last Record Date
April 30, 2024
Outstanding Shares
75,470,000 shares
Percentage of Shares Shorted
3.70%
Today's Trading Volume
469,380 shares
Average Trading Volume
388,998 shares
Today's Volume Vs. Average
121%
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook
Short Selling Xenon Pharmaceuticals ?

Sign up to receive the latest short interest report for Xenon Pharmaceuticals and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History

XENE Short Interest Over Time

XENE Days to Cover Over Time

XENE Percentage of Float Shorted Over Time

Xenon Pharmaceuticals Short Interest History

Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
4/30/20242,790,000 shares $113.41 million +6.5%N/A7.8 $40.65
4/15/20242,620,000 shares $108.23 million -5.1%N/A7.3 $41.31
3/31/20242,760,000 shares $118.82 million +5.3%N/A7 $43.05
3/15/20242,620,000 shares $115.18 million -3.0%N/A5.7 $43.96
2/29/20242,700,000 shares $127.44 million +6.7%N/A5.3 $47.20
2/15/20242,530,000 shares $123.19 million -10.0%N/A4.2 $48.69
1/31/20242,810,000 shares $127.07 million +12.0%N/A4.2 $45.22
1/15/20242,510,000 shares $113.18 million +13.1%N/A3.6 $45.09
12/31/20232,220,000 shares $102.25 million -5.9%N/A3.3 $46.06
12/15/20232,360,000 shares $97.73 million +20.4%N/A3.6 $41.41
11/30/20231,960,000 shares $71.70 million +14.6%N/A3.3 $36.58
11/15/20231,710,000 shares $49.85 million -2.8%N/A3.4 $29.15
10/31/20231,760,000 shares $54.56 million -10.2%N/A4.2 $31.00
10/15/20231,960,000 shares $68.87 million -26.3%N/A5.2 $35.14
9/30/20232,660,000 shares $90.87 million -4.0%N/A7.2 $34.16
9/15/20232,770,000 shares $102.10 million -0.4%N/A8.6 $36.86
8/31/20232,780,000 shares $108.36 million +2.2%N/A8.5 $38.98
8/15/20232,720,000 shares $101.62 million +2.6%N/A7.8 $37.36
7/31/20232,650,000 shares $97.84 million -4.3%N/A7.8 $36.92
7/15/20232,770,000 shares $107.61 million -10.9%N/A7.7 $38.85
6/30/20233,110,000 shares $119.74 million -2.8%N/A8.6 $38.50
6/15/20233,200,000 shares $134.50 million +9.6%N/A8.3 $42.03
5/31/20232,920,000 shares $112.51 million -3.6%N/A7.5 $38.53
5/15/20233,030,000 shares $126.47 million -12.2%N/A7.5 $41.74
4/30/20233,450,000 shares $138.97 million -1.2%N/A8.5 $40.28
4/15/20233,490,000 shares $124.24 million -11.4%N/A9 $35.60
3/31/20233,940,000 shares $141.01 million +7.7%N/A9.8 $35.79
3/15/20233,660,000 shares $124.37 million +16.2%N/A9.3 $33.98
2/28/20233,150,000 shares $124.30 million +2.9%N/A8.1 $39.46
2/15/20233,060,000 shares $118.76 million +1.0%N/A8.3 $38.81
1/31/20233,030,000 shares $118.44 million -16.5%N/A8 $39.09
1/15/20233,630,000 shares $131.41 million +1.4%N/A9.5 $36.20
12/30/20223,580,000 shares $141.16 million -6.3%N/A9.6 $39.43
12/15/20223,820,000 shares $145.81 million +2.4%N/A10.4 $38.17
11/30/20223,730,000 shares $137.56 million +1.4%N/A10.7 $36.88
11/15/20223,680,000 shares $128.03 million +4.8%N/A10.3 $34.79
10/31/20223,510,000 shares $128.36 million +9.0%N/A9 $36.57
10/15/20223,220,000 shares $111.64 million +15.8%N/A8.2 $34.67
9/30/20222,780,000 shares $100.36 million +7.3%N/A6.9 $36.10
9/15/20222,590,000 shares $101.79 million +9.8%N/A5.9 $39.30
Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some
8/31/20222,360,000 shares $91.59 million +28.3%N/A4.6 $38.81
8/15/20221,840,000 shares $69.13 million -17.5%N/A3.5 $37.57
7/31/20222,230,000 shares $73.92 million -5.9%N/A4.2 $33.15
7/15/20222,370,000 shares $76.29 million +6.8%N/A4.5 $32.19
6/30/20222,220,000 shares $67.53 million -7.9%N/A4.1 $30.42
6/15/20222,410,000 shares $69.43 million -2.0%N/A4.3 $28.81
5/31/20222,460,000 shares $64.82 million -6.1%N/A5.2 $26.35
5/15/20222,620,000 shares $78.02 million +30.4%N/A5.7 $29.78
4/30/20222,010,000 shares $56.82 million -6.5%N/A4.8 $28.27
4/15/20222,150,000 shares $72.61 million -0.9%N/A5.2 $33.77
3/31/20222,170,000 shares $66.34 million -4.4%N/A4.6 $30.57
3/15/20222,270,000 shares $63.72 million +0.4%N/A5.6 $28.07
2/28/20222,260,000 shares $71.64 million +3.2%N/A5.4 $31.70
2/15/20222,190,000 shares $71.81 million +5.3%N/A4.9 $32.79
1/31/20222,080,000 shares $56.41 million +11.8%N/A4.3 $27.12
1/15/20221,860,000 shares $59.45 million +5.1%N/A3.6 $31.96
12/31/20211,770,000 shares $55.29 million -16.5%N/A3.1 $31.24
12/15/20212,120,000 shares $56.33 million +26.2%N/A1 $26.57
11/30/20211,680,000 shares $44.86 million -7.2%N/A0.8 $26.70
11/15/20211,810,000 shares $57.34 million +5.9%N/A0.9 $31.68
10/29/20211,710,000 shares $53.27 million -13.6%N/A0.8 $31.15
10/15/20211,980,000 shares $66.65 million +121.6%N/A1 $33.66
9/30/2021893,500 shares $13.65 million +52.4%N/A0.5 $15.28
9/15/2021586,400 shares $10.13 million +10.5%1.6%3.1 $17.28
8/31/2021530,600 shares $9.37 million -20.4%1.4%2.8 $17.65
8/13/2021666,500 shares $12.30 million -6.9%1.8%3.5 $18.45
7/30/2021715,700 shares $12.36 million -0.3%2.0%3.9 $17.27
7/15/2021717,700 shares $12.70 million +12.1%1.8%4.3 $17.69
6/30/2021640,500 shares $11.93 million +0.7%1.6%3.5 $18.62
6/15/2021636,100 shares $11.44 million -3.2%1.7%3.5 $17.99
5/28/2021657,400 shares $12.14 million -13.5%1.8%4.2 $18.47
5/14/2021759,600 shares $12.77 million -3.4%N/A3.9 $16.81
4/30/2021786,600 shares $14.40 million +0.5%N/A4.3 $18.31
4/15/2021782,900 shares $15.25 million +5.8%N/A3.8 $19.48
3/31/2021739,700 shares $12.94 million -13.8%N/A4 $17.49
3/15/2021858,200 shares $17.64 million -9.1%N/A4.2 $20.55
2/26/2021943,900 shares $17.10 million -3.4%N/A5.3 $18.12
2/12/2021977,100 shares $14.72 million -5.1%N/A5.9 $15.07
1/29/20211,030,000 shares $15.30 million -3.7%N/A6.4 $14.85
1/15/20211,070,000 shares $16.65 million -6.1%N/A6.8 $15.56
12/31/20201,140,000 shares $18.29 million +36.4%N/A8.1 $16.04
12/15/2020835,600 shares $10.11 million +0.8%N/A6.1 $12.10
11/30/2020829,400 shares $9.46 million +2.9%N/A7.6 $11.40
10/30/2020720,700 shares $6.93 million -45.0%N/A6.8 $9.62
10/15/20201,310,000 shares $14.63 million -4.4%N/A13.3 $11.17
9/30/20201,370,000 shares $15.17 million -0.7%N/A13.1 $11.07
9/15/20201,380,000 shares $15.18 million -0.7%N/A13.2 $11.00
8/31/20201,390,000 shares $16.89 million +14.9%N/A9.9 $12.15
8/14/20201,210,000 shares $13.09 million +7.1%N/A6.5 $10.82
7/31/20201,130,000 shares $12.35 million +9.7%N/A6.1 $10.93
Warren Buffett's "mystery stock" (Ad)

WARNING: Read This Before the Next Fed Meeting Investors are looking to the Fed with high hopes for interest rate relief. Unfortunately, many have no idea there's another major story unfolding right now, one that could be worth $40 trillion.

This Wall Street millionaire just stepped forward with all the details, and how it could make some
7/15/20201,030,000 shares $12.39 million +12.3%N/A5.4 $12.03
6/30/2020917,600 shares $11.02 million +16.7%N/A4.4 $12.01
6/15/2020786,100 shares $9.44 million +5.8%N/A3.2 $12.01
5/29/2020742,700 shares $9.43 million -0.1%N/A2.9 $12.70
5/15/2020743,600 shares $9.46 million +2.7%N/A3.2 $12.72
4/30/2020723,800 shares $9.38 million +8.5%N/A2.8 $12.96
4/15/2020667,400 shares $9.31 million +18.6%N/A2.4 $13.95
3/31/2020562,700 shares $6.38 million -4.8%N/A1.8 $11.34
3/13/2020591,300 shares $7.60 million +29.8%2.6%2.3 $12.86
2/28/2020455,400 shares $4.56 million +9.7%2.0%1.7 $10.01
2/14/2020415,300 shares $5.34 million +1.1%N/A1.5 $12.86
1/31/2020410,900 shares $5.66 million +4.2%1.7%1.7 $13.77
1/15/2020394,200 shares $6.07 million -8.3%1.6%1.8 $15.40
12/31/2019429,800 shares $6.66 million -24.4%2.1%2.4 $15.50

XENE Short Interest - Frequently Asked Questions

What is Xenon Pharmaceuticals' current short interest?

Short interest is the volume of Xenon Pharmaceuticals shares that have been sold short but have not yet been covered or closed out. As of April 30th, traders have sold 2,790,000 shares of XENE short. Learn More on Xenon Pharmaceuticals' current short interest.

What is a good short interest ratio for Xenon Pharmaceuticals?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. XENE shares currently have a short interest ratio of 8.0. Learn More on Xenon Pharmaceuticals's short interest ratio.

Which institutional investors are shorting Xenon Pharmaceuticals?

As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Xenon Pharmaceuticals: Concourse Financial Group Securities Inc.. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission.

Is Xenon Pharmaceuticals' short interest increasing or decreasing?

Xenon Pharmaceuticals saw a increase in short interest in the month of April. As of April 30th, there was short interest totaling 2,790,000 shares, an increase of 6.5% from the previous total of 2,620,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

How does Xenon Pharmaceuticals' short interest compare to its competitors?

Here is how the short interest of companies in the sector of "medical" compare to Xenon Pharmaceuticals: IDEAYA Biosciences, Inc. (16.17%), Corcept Therapeutics Incorporated (22.07%), Arrowhead Pharmaceuticals, Inc. (7.74%), Summit Therapeutics Inc. (28.19%), Biohaven Ltd. (10.91%), TG Therapeutics, Inc. (27.08%), MorphoSys AG (0.83%), Avidity Biosciences, Inc. (11.91%), Amicus Therapeutics, Inc. (9.71%), Ultragenyx Pharmaceutical Inc. (5.59%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: T-Mobile US, Inc. ($3.98 billion), Occidental Petroleum Co. ($3.35 billion), Charter Communications, Inc. ($3.06 billion), General Motors ($2.88 billion), Moderna, Inc. ($2.32 billion), Tractor Supply ($2.27 billion), Royal Caribbean Cruises Ltd. ($2.22 billion), Coinbase Global, Inc. ($2.18 billion), Williams-Sonoma, Inc. ($1.95 billion), and Chesapeake Energy Co. ($1.52 billion). View all of the most shorted stocks.

What does it mean to sell short Xenon Pharmaceuticals stock?

Short selling XENE is an investing strategy that aims to generate trading profit from Xenon Pharmaceuticals as its price is falling. XENE shares are trading up $0.62 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Xenon Pharmaceuticals?

A short squeeze for Xenon Pharmaceuticals occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of XENE, which in turn drives the price of the stock up even further.

How often is Xenon Pharmaceuticals' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including XENE, twice per month. The most recent reporting period available is April, 30 2024.



More Short Interest Resources from MarketBeat

This page (NASDAQ:XENE) was last updated on 5/20/2024 by MarketBeat.com Staff

From Our Partners